Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma.
Saved in:
| Title: | Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma. |
|---|---|
| Authors: | Lim SM; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Kang SS; JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-si, South Korea., Kim DK; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.; Brain Korea 21 PLUS Project for Medical Science, College of Medicine, Yonsei University, Seoul, South Korea., Lee SH; JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-si, South Korea., Synn CB; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.; Brain Korea 21 PLUS Project for Medical Science, College of Medicine, Yonsei University, Seoul, South Korea., Baek S; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Yang SM; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Han YJ; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Kim MH; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Han H; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Na K; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Kim YT; Brain Korea 21 PLUS Project for Medical Science, College of Medicine, Yonsei University, Seoul, South Korea., Yun MR; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.; Yonsei New Il Han Institute for Integrative Lung Cancer Research, Seoul, South Korea., Kim JH; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Byeon Y; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Kim YS; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Lee JB; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Hong MH; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Curtin JC; Janssen R&D, Spring House, Pennsylvania., Patel B; Janssen R&D, Spring House, Pennsylvania., Bergiers I; Janssen R&D, Beerse, Belgium., Pyo KH; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.; Yonsei New Il Han Institute for Integrative Lung Cancer Research, Seoul, South Korea., Cho BC; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.; JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-si, South Korea.; Brain Korea 21 PLUS Project for Medical Science, College of Medicine, Yonsei University, Seoul, South Korea.; Department of Research Support, Yonsei Biomedical Research Institute, Yonsei University College of Medicine, Seoul, South Korea.; Yonsei New Il Han Institute for Integrative Lung Cancer Research, Seoul, South Korea. |
| Source: | Cancer research communications [Cancer Res Commun] 2024 Jul 01; Vol. 4 (7), pp. 1748-1764. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
